Pages that link to "Q28275665"
Jump to navigation
Jump to search
The following pages link to Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease (Q28275665):
Displaying 50 items.
- A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence (Q26744488) (← links)
- Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents (Q26825364) (← links)
- Pediatric fatty liver disease: role of ethnicity and genetics (Q27026295) (← links)
- Pediatric non-alcoholic fatty liver disease: New insights and future directions (Q33563887) (← links)
- Body composition variables as predictors of NAFLD by ultrasound in obese children and adolescents (Q33591710) (← links)
- Autophagy protects against palmitate-induced apoptosis in hepatocytes (Q33712340) (← links)
- Identification and treatment of metabolic complications in pediatric obesity (Q33893011) (← links)
- Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital (Q34005976) (← links)
- Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. (Q34091776) (← links)
- Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease (Q34395446) (← links)
- Review article: the management of paediatric nonalcoholic fatty liver disease (Q34440962) (← links)
- Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population (Q34505214) (← links)
- Comparison between a pediatric health promotion center and a pediatric obesity clinic in detecting metabolic syndrome and non-alcoholic fatty liver disease in children. (Q34591965) (← links)
- Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study. (Q34623657) (← links)
- Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets (Q34636684) (← links)
- Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease (Q34690684) (← links)
- Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods (Q34746071) (← links)
- Physical Activity is Related to Fatty Liver Marker in Obese Youth, Independently of Central Obesity or Cardiorespiratory Fitness (Q35014575) (← links)
- Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk (Q35171570) (← links)
- High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia (Q35216069) (← links)
- Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents (Q35589319) (← links)
- Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease (Q35629725) (← links)
- Genetic variation in the mouse model of Niemann Pick C1 affects female, as well as male, adiposity, and hepatic bile transporters but has indeterminate effects on caveolae (Q35673916) (← links)
- Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease (Q36038820) (← links)
- Aging modulates susceptibility to mouse liver Mallory-Denk body formation (Q36085640) (← links)
- Risk Score Model for Predicting Sonographic Non-alcoholic Fatty Liver Disease in Children and Adolescents (Q36244818) (← links)
- An exploration of prevalence and associated factors of nonalcoholic Fatty liver disease in the taiwanese police service. (Q36349054) (← links)
- Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease. (Q36400556) (← links)
- Epidemiology and Natural History of NAFLD. (Q37041241) (← links)
- Fatty liver disease in an autopsy series of children and adolescents (Q37082683) (← links)
- Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis (Q37177461) (← links)
- Association between UCP3 gene polymorphisms and nonalcoholic fatty liver disease in Chinese children (Q37221541) (← links)
- A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. (Q37337449) (← links)
- Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. (Q37362755) (← links)
- Genetic and clinical markers of elevated liver fat content in overweight and obese Hispanic children (Q37373386) (← links)
- Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease (Q37405640) (← links)
- Fatty liver in childhood (Q37636566) (← links)
- The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease (Q37736540) (← links)
- Use of metformin in pediatric age. (Q37848915) (← links)
- Unbalanced oxidant-antioxidant status and its effects in pediatric diseases. (Q37908224) (← links)
- Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. (Q37976341) (← links)
- Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk. (Q38021479) (← links)
- Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets (Q38160948) (← links)
- Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease (Q38178585) (← links)
- Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis (Q38272635) (← links)
- Paediatric non-alcoholic fatty liver disease: an overview (Q38370919) (← links)
- Imaging patterns of fatty liver in pediatric patients (Q38509320) (← links)
- The latest idea in NAFLD/NASH pathogenesis (Q38550442) (← links)
- Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease (Q38559075) (← links)
- Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress (Q38820176) (← links)